PathwayAndexanet Alfa: Considerations and Practical ApplicationsOwusu, Kent A. PharmD*; Effendi, Muhammad K. PharmD†,‡; DeFilippo, Nicholas A. PharmD candidate*,§; Reardon, David P. PharmD¶; Ian Lee, Alfred MD, PhD‖Author Information From the *Department of Pharmacy, Yale New Haven Health, New Haven, CT †Department of Pharmacy, Ernest Mario School of Pharmacy, RutgersPiscataway, NJ. ‡Capital Health Regional Medical Center, Trenton, NJ §University of Connecticut School of Pharmacy, Storrs, CT ¶Pharmacy Member Services, Vizient Inc., Irving, TX ‖Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. Received for publication March 25, 2019; accepted April 24, 2019. Reprints: Kent A. Owusu, PharmD, Department of Pharmacy, Yale New Haven Hospital, 20 York Street, New Haven, CT 06511. E-mail: Kent.Owusu@ynhh.org. Critical Pathways in Cardiology: December 2019 - Volume 18 - Issue 4 - p 200-206 doi: 10.1097/HPC.0000000000000190 Buy Metrics Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.